Evaluating vaccines for HIV prevention using nonhuman primates
Official title: Simian Vaccine Evaluation Unit: Maintenance of Nonhuman Primates
Funded at University of Louisiana at Lafayette · NIH-10381438 · Data updated 2026-11-12
This study is looking at how well new vaccines can work to prevent HIV/AIDS by testing them on nonhuman primates, and it's all about finding better ways to protect people from the virus.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Louisiana at Lafayette NIH-funded |
| Lab location | 1 site (Lafayette, United States) |
| Project start | April 1, 2020 |
| Project end | March 31, 2027 |
| Funding year | 2021 |
| Award (this year) | $109,172 |
| NIH project number | 75N93020D00008-P00001-759302000002-1 |
| Project ID | NIH-10381438 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research are individuals at high risk for HIV infection who may eventually receive vaccines developed through these studies.
✕Less likely to help
Patients who are already living with HIV or those who do not have access to HIV prevention strategies may not benefit directly from this research.
What this research studies
This research focuses on the use of nonhuman primates to evaluate potential vaccines for HIV/AIDS. It involves maintaining a breeding colony and providing resources for preclinical studies that assess the immune responses generated by candidate vaccines. The program aims to identify effective strategies for preventing HIV infection by testing vaccine efficacy and enhancing immune responses. Researchers will conduct thorough evaluations to understand how these vaccines can control or prevent viral infections.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines that prevent HIV infection in humans.
How similar studies have gone: Other research has shown success in using nonhuman primates for vaccine evaluation, indicating that this approach is well-established and has the potential for significant breakthroughs.
Where this research is happening
-
University of Louisiana at Lafayette
Lafayette, United States Active
Researchers
- Principal investigator: Villinger, Francois — University of Louisiana at Lafayette
- Study coordinator: Villinger, Francois
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.